Benzinga's Top #PreMarket Gainers By: Benzinga via Benzinga March 27, 2015 at 08:20 AM EDT Orexigen Therapeutics, Inc. (NASDAQ: OREX) shares gained 10.62% to $8.02 in the pre-market trading session following Thursday's EC ... Read More >> Related Stocks: Biomarin Pharmaceuticals Dow Chemical Esperion Theraptc Olin Corp The Finish Line, Inc. - Class A Common Stock